Walleye Capital LLC - BIOTECH ACQUISITION COMPANY ownership

BIOTECH ACQUISITION COMPANY's ticker is BIOT and the CUSIP is G1125A108. A total of 77 filers reported holding BIOTECH ACQUISITION COMPANY in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
Walleye Capital LLC ownership history of BIOTECH ACQUISITION COMPANY
ValueSharesWeighting
Q4 2022$1,188,799
+1.8%
117,7040.0%0.02%0.0%
Q3 2022$1,168,000
+0.3%
117,7040.0%0.02%
-31.2%
Q2 2022$1,165,000
+44.4%
117,704
+43.9%
0.03%
+45.5%
Q1 2022$807,000
-13.2%
81,797
-13.4%
0.02%
-24.1%
Q4 2021$930,00094,4890.03%
Other shareholders
BIOTECH ACQUISITION COMPANY shareholders Q1 2022
NameSharesValueWeighting ↓
RiverPark Advisors, LLC 799,001$7,930,0002.58%
Corbin Capital Partners, L.P. 928,124$9,207,0002.29%
Cohanzick Management, LLC 799,001$7,926,0001.92%
RPO LLC 379,021$3,762,0000.91%
Arena Capital Advisors, LLC- CA 300,000$2,978,0000.90%
Alpha Wave Global, LP 532,570$5,286,0000.62%
MIZUHO SECURITIES USA LLC 444,957$4,383,0000.60%
MMCAP International Inc. SPC 599,321$5,945,0000.47%
GLAZER CAPITAL, LLC 2,285,000$22,667,0000.42%
CVI Holdings, LLC 292,563$2,904,0000.22%
View complete list of BIOTECH ACQUISITION COMPANY shareholders